MCH ANALYSIS RESEARCHMain site ↗
Information Technology

IT Consulting & Other Services

6 companies under coverage.

Coverage

IT Consulting & Other Services


Equity Research

EPAM Systems Inc (EPAM)

HOLD. 12-month probability-weighted target $105 (-7% vs spot). Gross Margin explains 52% of Monte Carlo outcome variance.

EPAMEquity ResearchMonte Carlo
11 October 2026Rating: HOLD · Fair value vs price +8.1%
Equity Research

International Business Machines (IBM)

HOLD. 12-month probability-weighted target $257 (+13% vs spot). P/E Multiple explains 58% of Monte Carlo outcome variance.

IBMEquity ResearchMonte Carlo
10 October 2026Rating: HOLD · Fair value vs price -5.4%
Equity Research

Kyndryl Holdings Inc (KD)

HOLD. 12-month probability-weighted target $13 (+8% vs spot). Gross Margin explains 64% of Monte Carlo outcome variance.

KDEquity ResearchMonte Carlo
10 October 2026Rating: HOLD · Fair value vs price -13.8%
Equity Research

Cognizant Technology Solutions Corp Class A (CTSH)

SELL. 12-month probability-weighted target $38 (-36% vs spot). Gross Margin explains 50% of Monte Carlo outcome variance.

CTSHEquity ResearchMonte Carlo
10 October 2026Rating: SELL · Fair value vs price -22.6%
Equity Research

Gartner Inc (IT)

SELL. 12-month probability-weighted target $127 (-33% vs spot). P/E Multiple explains 52% of Monte Carlo outcome variance.

ITEquity ResearchMonte Carlo
10 October 2026Rating: SELL · Fair value vs price -32.9%
Equity Research

Accenture plc (ACN)

SELL. 12-month probability-weighted target $116 (-44% vs spot). Gross Margin explains 51% of Monte Carlo outcome variance.

ACNEquity ResearchMonte Carlo
10 October 2026Rating: SELL · Fair value vs price -33.4%
MCH ANALYSIS · All research · Research, not personal financial advicemchadvisoryservices.com ↗ · Research Standard v4 (decision-level) · Research OS ros-1.20.0 · US-listed

MCH Analysis is a general investment-research publication of MCH Advisory (Pty) Ltd. It is not personal financial advice and does not take your circumstances into account. MCH is not a licensed financial services provider or a registered investment adviser. Past performance, whether actual or simulated, does not predict future results. Subscriber Agreement | Privacy and Cookie Notice | Research Governance Policies